A committee that advises the Centers for Disease Control and Prevention is going to review various aspects of COVID-19 vaccines, including concerns about the persistence of messenger ribonucleic acid (mRNA), according to a new document.
The Advisory Committee on Immunization Practices (ACIP) work group on COVID-19 vaccines will review data on the shots related to their safety, effectiveness, and immunogenicity, according to the Aug. 20 document, which was released by the CDC.
Members also plan to look at gaps in existing knowledge “relating to bio distribution, pharmacokinetics, and persistence of the spike protein, mRNA, and lipid nanoparticles to inform immunization recommendations,” the document states….